Author

K. S. Olsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:proteomics· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Rubinsteyn· 1 shared A. Webb· 1 shared A. Woods· 1 shared B. Carpenter· 1 shared B. G. Vincent· 1 shared B. Vincent· 1 shared C. A. Haiman· 1 shared C. C. Smith· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Rubinsteyn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

K. S. Olsen, O. Jadi, S. Dexheimer, D. Bortone, S. P. Vensko, S. Bennett, H. Tang, M. Diiorio, T. Saran, D. Dingfelder, Q. Zhu, Y. Wang, C. A. Haiman, L. Pooler, X. P. Sheng, , B. Vincent

The paper identifies shared minor histocompatibility antigens (mHAs) that could enhance graft versus leukemia (GvL) effects while minimizing graft versus host disease (GvHD) in allogeneic hematopoietic cell transplants.

bioRxiv · Aug 12, 2022 · PreprintCancer Biology

A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease

V. K. Baxter, E. J. Anderson, S. A. Taft-Benz, K. S. Olsen, M. Sambade, K. M. Gentry, W. A. Beck, J. Garness, A. Woods, M. Fini, B. Carpenter, C. C. Smith, M. T. Heise, B. G. Vincent, A. Rubinsteyn

This study evaluates a SARS-CoV-2 peptide vaccine in mice, finding it induces T-cell responses but fails to prevent infection or disease.

bioRxiv · Feb 22, 2022 · PreprintImmunology